GlassScriptPhysician profile
William M Merhi
NPI 1386786044
$114,238.02
in general payments reported to CMS, 2019-2025
8 companies · $2,485 in 2025
The $2,485 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $17K · 2021: $2,429 · 2022: $13K · 2023: $22K · 2024: $19K · 2025: $2,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Food and Beverage: $5,002 · Travel and Lodging: $3,907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,500.00 |
| Food and Beverage | $5,002.31 |
| Travel and Lodging | $3,906.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $53,940.50 | 2019-2020 | |
| Medtronic, INC. | $50,697.31 | 2021-2025 | Corevalve Evolut R, Apollotm |
| Abbott Laboratories | $4,050.02 | 2019-2025 | Tendyne, Navitor, Mitraclip |
| Edwards Lifesciences Corporation | $2,813.94 | 2021-2024 | Evoque, Pascal, Sapien 3 Ultra Resilia |
| Ancora Heart, INC. | $1,377.60 | 2021-2024 | Accucinch |
| Boston Scientific Corporation | $1,224.07 | 2019-2020 | |
| Livanova USA, INC. | $78.80 | 2023 | Tandemheart |
| Baxter Healthcare | $55.78 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Merhi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.